Pilocytic Astrocytoma
What's New
Last Posted: May 05, 2024
- [Pilocytic astrocytoma with KRAS gene mutation: a clinicopathological analysis of two cases].
T P Yu, et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 0 (5) 477-479 - Deep learning based clinico-radiological model for paediatric brain tumor detection and subtype prediction.
Abhishek Mahajan et al. Explor Target Antitumor Ther 2023 4(4) 669-684 - [Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas].
Liu Q Q, et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 0 (9) 658-663 - Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.
Hong Bujung, et al. Acta neurochirurgica 2018 0 (11) 2237-2248 - Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.
Gao Y, et al. European journal of cancer (Oxford, England : 1990) 2018 0 168-178 - Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas.
Sippl Christoph, et al. Oncology letters 2018 0 (2) 1600-1606 - Primary spinal pilocytic astrocytoma: clinical study with long-term follow-up in 16 patients and a literature review.
Jiang Yong, et al. Neurosurgical review 2019 0 (2) 719-727 - Is it a new culprit? "TERT promoter mutation" in an aggressive pediatric pilocytic astrocytoma.
Francis Jacintha Vikeneswary, et al. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020 0 (3) 1003-1008 - Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
Ishi Yukitomo, et al. Journal of neurosurgery 2020 0 (3) 733-741 - Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas.
Biczok Annamaria, et al. Acta neuropathologica communications 2021 0 (1) 119
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: